Catalyst Wire Dossier Catalyst Wire Dossier

Sm-TSP-2/Alhydrogel

Sm-TSP-2 vaccine with Alhydrogel adjuvant (with or without GLA-AF)
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Sm-TSP-2/Alhydrogel, covering 2017-06-26 to 2017-06-26. Get the full timeline:

Most recent: Clinical Trial Update: A Phase I Study of the Safety, Reactogenicity, and Immunogenicity of Sm-TSP-2/Alhydrogel® With or Without GLA-AF for Intestinal Schistosomiasis in Healthy Adults [Phase 1]

See pricing